Flex Pharma (FLKS) – Management Comments
-
Flex Pharma (FLKS) Reports Merger Agreement with Salarius Pharmaceuticals to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer
-
Flex Pharma (FLKS) Announces Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in Multiple Sclerosis
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to FLKS Stock Lookup